RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections

Sahil Khanna, Darrell S. Pardi, Courtney Jones, William D. Shannon, Carlos Gonzalez, Ken Blount

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections'. Together they form a unique fingerprint.

Medicine & Life Sciences